• 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け

特許

68,026 件
全IP種別
PATENTFIELDで検索
IPを掲載
係属中

Target nucleic acid sequenc...

Target nucleic acid sequence detection

係属中

Active tuberculosis

Diagnosing active tuberculosis based merely on signs and symptoms is difficult,[55] as is diagnosing the disease in those who are immunosuppressed.[56] A diagnosis of TB should, however, be conside...

係属中

Active tuberculosis

Diagnosing active tuberculosis based merely on signs and symptoms is difficult,[55] as is diagnosing the disease in those who are immunosuppressed.[56] A diagnosis of TB should, however, be conside...

係属中

Photodynamic therapy

Photodynamic therapy (PDT), sometimes called photochemotherapy, is a form of phototherapy using nontoxic light-sensitive compounds that are exposed selectively to light, whereupon they become toxic...

権利維持

Alzheimer's disease

Alzheimer's disease (AD), also known in medical literature as Alzheimer disease, is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventuall...

係属中

Diels–Alder reaction

The Diels–Alder reaction is an organic chemical reaction (specifically, a [4+2] cycloaddition) between a conjugated diene and a substituted alkene, commonly termed the dienophile, to form a substit...

係属中

Glucose-dependent insulinot...

Gastric inhibitory polypeptide (GIP), also known as the glucose-dependent insulinotropic peptide is a member of the secretin family of hormones.[1] GIP, along with glucagon-like peptide-1 (GLP-1...

権利維持

Metal extraction

Extractive metallurgy is the practice of removing valuable metals from an ore and refining the extracted raw metals into a purer form. In order to convert a metal oxide or sulfide to a purer metal,...

係属中

Intron-mediated recombination

Intron-mediated recombination

権利維持

Streptavidin mutants

Most attempts at mutating streptavidin result in a lowered biotin-binding affinity, which is to be expected in such a highly optimised system. However, a recently engineered mutant of streptavidin,...

権利維持

Antiplatelet agent

An antiplatelet drug (antiaggregant) is a member of a class of pharmaceuticals that decrease platelet aggregation [1] and inhibit thrombus formation. They are effective in the arterial circulation,...

係属中

Identification of expresse...

Identification of expressed genes

係属中

Silicon surface coating wit...

Silicon surface coating with biomolecules

権利維持

Anti-cancer gene therapy

Introduction of tumor suppressor genes into rapidly dividing cells has been thought to slow down or arrest tumor growth. Adenoviruses are a commonly utilized vector for this purpose. Much research ...

権利維持

Determining bacteria/fungi ...

Determining bacteria/fungi species

係属中

Transcriptional regulation

Transcriptional regulation is the change in gene expression levels by altering transcription rates.

係属中

Inference sequencing by hyb...

Inference sequencing by hybridization

権利維持

Antibacterial/antifungal pe...

Antibacterial/antifungal peptides

権利維持

Modified red blood cells

Red blood cells (RBCs), also called erythrocytes, are the most common type of blood cell and the vertebrate organism's principal means of delivering oxygen (O2) to the body tissues--via blood flow ...

権利維持

Pyronin antibacterials

Pyronin antibacterials

  • 最初
  • 前
  • …
  • 1843
  • 1844
  • 1845
  • 1846
  • 1847
  • 1848
  • 1849
  • 1850
  • 1851
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

© 2026 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム